NeuroOne Medical Technologies Corporation NMTC · Stock Open NeuroOne Medical Technologies Corporation in new tab
NeuroOne Medical Technologies Corporation Analysis (NMTC)
Is NeuroOne Medical Technologies Corporation a good investment? NeuroOne Medical Technologies Corporation (NMTC) is currently trading at 1.30 USD. Market analysts have a consensus price target of 7.27 USD. This suggests a potential upside from current levels.
Earnings Schedule: NeuroOne Medical Technologies Corporation is expected to release its next earnings report on Dec. 15, 2026. The market consensus estimate for Forward EPS is -0.28.
Investor FAQ
Does NeuroOne Medical Technologies Corporation pay a dividend?
No, it does not currently pay a dividend.
What asset class is NeuroOne Medical Technologies Corporation?
NeuroOne Medical Technologies Corporation is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Dec. 15, 2026. The company currently has a trailing EPS of -0.97.
Company Profile
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.
| Split Date | Split Ratio to 1 |
|---|---|
| April 1, 2021 | 0.33 |
| April 16, 2026 | 0.17 |
Community Discussion